Navigation Links
Diabetes Alliance to Feature 17 Presentations for Linagliptin and Investigational Compound Empagliflozin^ During the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Date:9/17/2013

RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 17, 2013 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (Lilly; NYSE: LLY) today announced they will feature five oral and 12 poster presentations for linagliptin and the investigational compound empagliflozin^ at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), which will take place in Barcelona from September 23 – 27.

Empagliflozin Data
A total of eight clinical abstracts for the investigational agent empagliflozin will be presented. Empagliflozin is a sodium glucose co-transporter 2 (SGLT2) inhibitor being investigated for the reduction of blood glucose levels in adults with type 2 diabetes (T2D). The emerging SGLT2 inhibitor class removes excess glucose through the urine by blocking glucose re-absorption by the kidney.

^Empagliflozin is an investigational compound. Its safety and efficacy have not been established.

Details of clinical presentations for empagliflozin are as follows:1

Tuesday, September 24, 12:30–1:30 CET, General Poster Session 

  • Empagliflozin as Add-on to Basal Insulin for 78 Weeks Improves Glycemic Control and Weight Loss in Insulin-Treated Type 2 Diabetes (T2DM) (Presenting Author: J. Rosenstock) [Poster No. 931]
  • Safety and Efficacy of Empagliflozin Monotherapy in a 52-Week Study in Japanese Patients with Type 2 Diabetes Mellitus (Presenting Author: H. J. Woerle) [Poster No. 930]
  • Metabolic Response to Sodium Glucose Transporter 2 (SGLT2) Inhibition with Empagliflozin in Patients with Type 2 Diabetes (T2D) (Presenting Author: E. Ferrannini) [Poster No. 932]

Tuesday
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
4. CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New Potential Diabetes Treatments To The Global Market
5. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
6. Valeritas Inc. Selects dLifes New Diabetes Patient Engagement Solution For Valeritas V-go Disposable Insulin Delivery Device
7. Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with type 2 diabetes in Europe
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. JDRF and BD Collaborate to Develop More Accurate and Reliable Glucose Monitoring Devices for People with Type 1 Diabetes
10. Eleven Integrated Health Systems Form Largest Private-Sector Diabetes Registry in United States
11. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Sept. 30, 2014 The signing of ... and New Jersey Health Foundation (NJHF) to work ... care programs has been announced by Rodger ... Kessler Foundation and James M. Golubieski , ... "The experience of New Jersey Health Foundation in ...
(Date:9/30/2014)... NEWPORT BEACH, Calif. , Sept. 30, 2014 ... prestigious accreditation of the American Association of Tissue ... Russell Cook , Chief Executive Officer. ... on-site inspection by a specially trained AATB inspector.  ... and administrative performance within the facility meets or ...
(Date:9/30/2014)... , Sept. 30, 2014 The Eastern European ... established medical-device providers as well as new medical-device manufacturers ... while simultaneously looking at ways to reduce the cost ... distributors is one of the effective means to achieve ... distribution market in Eastern European and provides profiles of ...
Breaking Medicine Technology:Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2Biostructures, LLC Earns AATB Accreditation 2Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3
... SAN DIEGO, Dec. 5, 2011 ForteBio®, Inc., a ... of biotherapeutic and pharmaceutical products, today announced the launch ... scientists – for the first time – to conduct ... and cost-efficiently at their lab bench. The new platform ...
... Bupa International has published two new health guides for ... information on vaccinations, medical insurance and emergency healthcare. ... a growing number of people relocate to foreign countries ... region is particularly needed, as the area,s many booming ...
Cached Medicine Technology:ForteBio Introduces BLItz™, a Revolutionary, Micro-volume Label-free Analysis Platform for Personal Assays 2ForteBio Introduces BLItz™, a Revolutionary, Micro-volume Label-free Analysis Platform for Personal Assays 3Bupa International Releases Health Guides to Hong Kong and Singapore 2
(Date:9/30/2014)... to be proactive about potential disease outbreaks like Ebola ... In an Editorial in the October issue of ... Allen Cheng from Monash University and Heath Kelly from ... health crises. , "Australia would do well to heed ... in co-ordinating a consistent and outward looking response," the ...
(Date:9/30/2014)... By Dennis Thompson ... -- The first confirmed case of Ebola has surfaced in ... from Liberia, federal health officials announced late Tuesday. The ... Hospital in Dallas, has been diagnosed with the deadly ... Prevention said in a late afternoon news conference. The ...
(Date:9/30/2014)... climate-changing carbon emissions will reduce other harmful air ... to a new study released today. The research ... in the final Clean Power Plan, the power ... and hospitalizations, and hundreds of heart attacks in ... study, Health Co-benefits of Carbon Standards for Existing ...
(Date:9/30/2014)... Sleep apnea is a potential health risk for millions of ... behind the disorder: a "fat" tongue. "This is the ... the tongue of obese patients with obstructive sleep apnea," study ... at the University of Pennsylvania Medical Center, said in a ... findings Oct. 1. Sleep apnea is a common disorder ...
(Date:9/30/2014)... Keystone Symposia will convene the first conference of its ... Health Series on "The Modes of Action of ... following the conclusion of the Grand Challenges Meeting for ... the Keystone Symposia Global Health Series, supported by the ... travel awards for 36 investigators from developing countries to ...
Breaking Medicine News(10 mins):Health News:CDC Confirms First Patient Diagnosed With Ebola in United States 2Health News:CDC Confirms First Patient Diagnosed With Ebola in United States 3Health News:Power plant standards could save thousands of US lives every year 2Health News:Power plant standards could save thousands of US lives every year 3Health News:Could a 'Fat Tongue' Be a Factor in Sleep Apnea? 2Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2
... on their way to office or back home, with the ... Manchester Piccadilly train stations//. This patient friendly system eliminates ... from 7 a.m. to 7 p.m. ,Such a ... for the request of the general public, demanding a quick ...
... effective anti-depressant is also found to interact with immune ... mechanism of serotonin inhibitors on human health//. ... Georgetown University Medical center have found that SSRI (Selective ... an effective antidepressant by passing between the neurons ...
... Researchers have identified an increased incidence of melanoma among the ... the March 1, 2006 issue// of CANCER, a peer-reviewed journal ... melanoma- an invasive form of skin cancer- is of the ... ,It is generally accepted that melanoma is by far ...
... who use vaginal washes run a higher risk of contracting HIV/AIDS.// ... led by Scott McClelland. The women who live in the sub-Saharan ... Kenyan women were examined during the course of the study. ... they washed with soap were four times more likely to be ...
... in the lymph nodes also, according to a recent research, ... mammalian immune response. // ,The dreaded disease ... mammal, and the immature parasites travel to the animal's liver. ... the liver cells and infect red blood cells, beginning the ...
... provided by researchers that faith healing and special diets also ... Melbourne led the research // which studied as many as ... served to extend the life of 25 people for a ... ,Dr Macmanus said that the data showed ...
Cached Medicine News:Health News:Invasive Skin Cancer On The Rise in Hispanics 2Health News:Malaria Can Develop In Lymph Nodes Also 2
... first fully automated blood ... North American market based ... Test™. The ORTHO ProVue™ ... while increasing productivity via ...
The ScanGel® automatic readings are done with a high resolution color video camera. Images can be stored and printed....
... are in need of MRI exams, many ... scanners. They have heard of, or experienced ... and noisy tubes of supercon scanners - ... people want is a patient-friendly MRI. Now ...
... early 1990s, the "Reversed" shoulder prosthesis has ... great success. More recently, an ever-growing number ... begun to champion this prosthesis and the ... This reversed technology is the result of ...
Medicine Products: